Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adrenal Insufficiency × 90 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 10 Neoplasms 8 Multiple Myeloma 8 Lung Neoplasms 6 Waldenstrom Macroglobulinemia 5 Stomach Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Uterine Cervical Neoplasms 3 Tuberous Sclerosis 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Papillomavirus Infections 3 Neoplasm Metastasis 3 Melanoma 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hematologic Neoplasms 3 Venous Thromboembolism 2 Urinary Bladder Neoplasms 2 Tobacco Use Disorder 2 Thoracic Neoplasms 2 Thoracic Diseases 2 Stomatitis 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms, Plasma Cell 2

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡